anewmeds.com (KLTO) Company Long-Term Loans and Borrowings

Graphic logo of Klotho Neurosciences (KLTO)

Klotho Neurosciences Inc (KLTO) focuses on developing methods to combat the aging of the central nervous system, with its primary capital concentrated in patents and intellectual property. However, geopolitical instability and sanctions hinder global testing and raw material supplies. The stock price trend on GURU.Markets, where the indicator stands at 0.00, reflects the asset's dynamics. Strict FDA oversight and R&D barriers provide a significant moat for the business.

KLTO (ANEW Medical) Company Long-Term Debt history from 09/18/2024 to 03/11/2026

Financial and market metric breakdowns for Klotho Neurosciences (KLTO)

- price and consensus price forecast:
Stock Price ANEW Medical|KLTO - Price Target Chart
- market capitalization data:
Market Value Klotho Neurosciences|KLTO - Total Company Value
- book capitalization data:
Net Asset Value per Share Klotho Neurosciences|KLTO - Company Book Value|Market Capitalization to Book Value Ratio anewmeds.com|KLTO - Aggregate Company Assets
- debt and liquidity data:
Debt to Equity Klotho Neurosciences Inc|KLTO - Long-Term Debt to Equity|Current Liabilities to Capital ANEW Medical|KLTO - Company Total Debt|Debt to Book Capital Klotho Neurosciences|KLTO - Company Long-Term Debts|Company Short-Term Loans and Borrowings Klotho Neurosciences
Fundamental company analysis:KLTO (Klotho Neurosciences Inc)
Manufactured products of anewmeds.com

An analysis of the long-term loan and borrowing trends for Klotho Neurosciences Inc. (KLTO) allows for an assessment of the balance between financial stability and the cost of development under strict FDA oversight. The dynamics of liabilities with a maturity of over one year define the boundaries of credit risk: rising debt signals a liquidity deficit, while its reduction confirms the effective capitalization of exclusive patents for neurodegeneration drugs.

Analysis of competing companies

biogen.com - Company Long-Term Debts|Company Long-Term Debt Neurocrine Biosciences, Inc. (NBIX)|RGC: Company Long-Term Loans and Borrowings|Company Long-Term Debt AXSM|ACAD (ACADIA Corp) - Long-Term Debt|XENE (Xenon Pharmaceuticals) - Company Long-Term Debt|Company Long-Term Debts VKTX|Company Long-Term Debt Supernus (SUPN)|Company Long-Term Debt CPRX (Catalyst Pharma)|DNLI: Company Long-Term Debt|HRMY - Long-Term Debt|Company Long-Term Liabilities Biohaven Ltd. BHVN|AMLX - Amount of Long-Term Liabilities|Company Long-Term Debts Trevi Therapeutics, Inc. TRVI|PRAX (Praxis Precision Medicines Inc) - Company Long-Term Loans and Borrowings|Company Long-Term Debt AVXL (Anavex Corp)|Long-Term Debt CeriBell EEG (CBLL)|Prothena (PRTA) - Company Long-Term Liabilities|Company Long-Term Loans and Borrowings ALEC (alector.com)|ANNX - Company Long-Term Debt|Company Long-Term Indebtedness Omeros Corp OMER|NGNE (Neurogene Corp) - Company Long-Term Debts|AC Immune Inc (ACIU) - Long-Term Debt|VYGR: Company Long-Term Liabilities|NMRA (neumoratx.com) - Company Long-Term Debts|SCLX - Company Long-Term Debt|Company Long-Term Loans and Borrowings TVGN|Alpha Cognition - Company Long-Term Debt|Long-Term Debt CGTX (cogrx.com)|Company Long-Term Debt IKT|Long-Term Debt Volume cassavasciences.com SAVA|ASRT: Company Long-Term Debts|COYA - Company Long-Term Liabilities|vistagen.com - Company Long-Term Debts|Ovid Therapeutics (OVID) - Long-Term Debt Volume|Company Long-Term Debts ABOS (Acumen Pharmaceuticals)|Long-Term Debt CRVO|Company Long-Term Debt Alterity Therapeutics ATHE|Company Long-Term Indebtedness clene.com (CLNN)|PepGen - Company Long-Term Debts|Company Long-Term Liabilities jupiterneurosciences.com JUNS|RLMD (Relmada Therapeutics) - Company Long-Term Debts|ANVS: Long-Term Debt|gracetx.com - Company Long-Term Debt|Long-Term Debt Volume Firefly Neuroscience, Inc.|NRSN - Company Long-Term Liabilities|Company Long-Term Loans and Borrowings Reviva Pharmaceuticals, Inc.|MTVA (MetaVia Inc) - Company Long-Term Debts|Long-Term Debt Volume NRXS (neuraxis.com)|HSDT - Company Long-Term Debt|Company Long-Term Indebtedness Passage Bio Inc. PASG|NEUP: Company Long-Term Debts|NERV: Company Long-Term Liabilities|ATHA: Company Long-Term Debt|ADXN (addextherapeutics.com) - Company Long-Term Debts|Company Long-Term Debt Alzamend Neuro Inc.|Company Long-Term Debt Cyclerion (CYCN)|Company Long-Term Liabilities Protagenic Therapeutics|Amount of Long-Term Liabilities KTTA (pasitheaclinics.com)|CRGT: Company Long-Term Debt|avenuetx.com - Long-Term Debt|BrainStorm Cell Therapeutics (BCLI) - Company Long-Term Debt|CARA - Company Long-Term Indebtedness|Company Long-Term Debts CHRO|Long-Term Debt Eliem Therapeutics Inc.|ITCI (Intra-Cellular Therapies Inc.) - Company Long-Term Liabilities|Company Long-Term Debts LBPH|Marinus Pharmaceuticals, Inc. (MRNS) - Company Long-Term Debt|Company Long-Term Loans and Borrowings NKGN (NKGen Biotech Inc)|NRBO: Company Long-Term Debt|Sage Therapeutics Inc - Long-Term Debt|Synaptogenix, Inc. - Company Long-Term Debt|TRVN: Company Long-Term Debts|vigilneuro.com (VIGL) - Company Long-Term Debt|WENA (Anew Medical Inc.) - Company Long-Term Debt|Company Long-Term Debt CERE (Cerevel)